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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYLGR5 and BMI1 mark intestinal stem cells in crypt base columnar cells and +4 position cells, respectively, but characterization of
functional markers in these cell populations is limited. ID1 maintains the stem cell potential of embryonic, neural, and long-
term repopulating hematopoietic stem cells. Here, we show in both human and mouse intestine that ID1 is expressed in cycling
columnar cells, +4 position cells, and transit-amplifying cells in the crypt. Lineage tracing revealed ID1+ cells to be self-renewing,
multipotent stem/progenitor cells that are responsible for the long-term renewal of the intestinal epithelium. Single ID1+ cells
can generate long-lived organoids resembling mature intestinal epithelium. Complete knockout of Id1 or selective deletion of Id1
in intestinal epithelium or in LGR5+ stem cells sensitizes mice to chemical-induced colon injury. These experiments identify ID1
as a marker for intestinal stem/progenitor cells and demonstrate a role for ID1 in maintaining the potential for repair in response
to colonic injury.INTRODUCTION
The gastrointestinal tract is an important site of interac-
tions between the host and the external environment.
An intact epithelium forms the first line of host defense
against numerous mechanical, chemical, and microbial-
driven attacks and rapidly self-renews as a mechanism
to maintain homeostasis (Barker et al., 2010; Quante
and Wang, 2009). This regeneration and replacement of
cells is driven by tissue-restricted adult stem cells located
at the base of the crypt. These cells undergo largely sym-
metric divisions, which upon competitive displacement
from contact with a Paneth cell niche in the small intes-
tine, stochastically generate a larger pool of more rapidly
dividing progenitor cells referred to as transit-amplifying
(TA) cells (Snippert et al., 2010). A Paneth-like cell fulfills
a similar function in the colon. In the small intestine, the
TA cells give rise to four terminally differentiated cell
types: enterocytes, goblet cells, enteroendocrine cells,
and Paneth cells. Two opposing models, the +4 model
and the crypt base columnar (CBC) cell model, describe
the exact location and identity of intestinal stem cells.
The +4 model was based on the presence of slowly
cycling, radiation-sensitive cells at the fourth cell position
from the bottom of the crypt that showed label retention
of BrdU (Potten, 1977). However, other studies suggested716 Stem Cell Reports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 Thethat the slender, immature, cycling cells wedged between
the Paneth cells, i.e., the CBC cells, are stem cells (Cheng,
1974). The ‘‘stemness’’ of these populations was later es-
tablished based on their ability to self-renew over long pe-
riods of time and produce all differentiated cell types of
the intestinal epithelium (Barker et al., 2007; Sangiorgi
and Capecchi, 2008). Still, the characterization of func-
tional markers in these stem cell populations will likely
contribute to our understanding of the response to crypt
injury.
Inhibitor of DNA binding 1 (ID1) facilitates cell-cycle
progression, inhibits differentiation in multiple cell
types, and plays an essential role in the self-renewal of
stem cells (Lasorella et al., 2014). It is sufficient for main-
taining murine embryonic stem cell self-renewal and plu-
ripotency in the absence of bone morphogenic protein
(Ying et al., 2003), and maintains embryonic stem cell
self-renewal by upregulation of Nanog and repression of
Brachyury expression (Romero-Lanman et al., 2012).
Loss of Id1 function leads to premature withdrawal of
neuroblasts from the cell cycle and inappropriate expres-
sion of neural-specific markers, in addition to a defect in
angiogenesis in the murine embryonic brain (Lyden
et al., 1999). High levels of Id1 expression define a sub-
population of GFAP+ cells in the subventricular zone
(SVZ) of adult mouse brain that are bona fide B1-typeAuthors
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intermediate levels of Id1 are associated with the more
committed progenitor C cells in the SVZ. In addition,
this hierarchy is maintained during gliomagenesis (Bar-
rett et al., 2012). Therefore, we hypothesized that ID1
might be a fate determinant of other adult stem cell
populations.
Here, we show that (1) ID1 expression in the gut is
restricted to CBC cells and the +4 position, which corre-
sponds to cells expressing LGR5 and BMI1, respectively,
as well as TA cells; (2) these ID1+ cells are self-renewing,
multipotent stem cells that are responsible for the long-
term renewal of the gut epithelium in lineage-tracing
experiments; (3) single Id1+ cells efficiently generate
long-lived organoids resembling mature intestinal epithe-
lium; and (4) knocking out Id1 in intestinal epithelial cells
impairs LGR5+ stem cell function and sensitizes animals to
chemical-induced injury to the colon.RESULTS AND DISCUSSION
Restricted Expression of ID1 at the Base of the
Intestinal Crypts
We examined expression of ID1 in the intestine using
a highly specific rabbit monoclonal anti-Id1 antibody
(Perk et al., 2006). ID1 expression throughout the small
intestinal epithelium of adult mice is confined to the
crypts, whereas the villi are negative (Figure 1A). ID1 is ex-
pressed in CBC cells interspersed between Paneth cells, +4
position cells, and TA cells (Figure 1B). The frequency of
ID1 positivity is greatest in the +4 to +10 position, with
less frequent expression in CBC cells and the higher TA
zone (Figure S1A available online). A similar pattern is
seen in the mouse colon: ID1+ cells are confined to the
bottom two-thirds of the crypt, and the upper, more
differentiated part of the crypt and the surface epithelial
cells rarely express ID1 (Figures 1C and 1D). In both the
small intestine and the colon, Id1 is present in every crypt
(Figures 1A and 1C). Ki67, a marker of proliferation, and
ID1 colocalize in the majority of cells in the crypts of
the small intestine and colon (Figure S2). In human small
intestine and colon, CBC cells, +4 position cells, and TA
cells are positive for ID1 (Figures 1E–1H). Low levels of
ID1 are also found in endothelial cells in normal mouse
and human intestine. Costaining for EGFP and ID1 in
Lgr5-EGFP-IRES-creERT knockin mice demonstrates ID1
immunoreactivity in LGR5+ stem cells (Figure 1I). Many
CBC cells that are positive for Lgr5-EGFP also express
ID1 protein, and some lacking Id1 are also observed.
Consistently, +4 position cells and some early TA cells
that are negative for Lgr5-EGFP are positive for ID1. Collec-
tively, these observations indicate that ID1 is a stem/pro-Stem Cell Rgenitor cell marker in both mouse and human colon
and small intestine.
ID1+ Cells Support the Renewal of Intestinal
Epithelium over Extended Periods
To study the potential of ID1+ cells to give rise to more
differentiated progeny, we crossed the Id1-IRES-creERT2
mouse strain (Nam and Benezra, 2009) with animals
bearing the Cre-activatable Rosa26-lox-stop-lox-lacZ allele.
Tamoxifen activates the CreERT2 fusion enzyme in Id1-
expressing cells, and Cre-mediated excision of the road-
block sequence in the Rosa26-lacZ reporter permanently
marks Id1+ cells and their progeny. After a single tamox-
ifen pulse, adult mice were sacrificed at 0.5, 1, 3, 7, 30,
60, 180, and 365 days after induction (Figure 2A). LacZ
activity is first observed in isolated ID1+ cells at the base
of the intestinal crypts 0.5 days postinduction. Approxi-
mately 25% of the crypts are labeled at this time
(compared with 100% by immunohistochemistry [IHC]),
likely reflecting incomplete recombination at the Rosa26
locus, which has also been observed in other cell types
(Nam and Benezra, 2009). Among the labeled crypts,
46% show evidence of LacZ expression in the stem cell
zone and 34% show expression in the TA cell zone (Fig-
ure 2B, left). The remaining 20% of the labeled crypts
exhibit LacZ+ cells in both zones. Among the 46% stem
cell zone-labeled crypts, more than half (54%) show
LacZ staining at the +4 position, one-third (33%) show
LacZ+ CBC cells, and 13% show staining in both popula-
tions (Figure 2B, right). Quantitative analysis of the
earliest LacZ+ cells indicates that the CBC and +4 position
cells have the highest Id1 promoter activity (Figure S1B).
From day 1 to day 30, there is a continual increase in
the number of cells labeled per crypt in both the small in-
testine and colon (Figure 2A). Ribbons of cells emanate
from the base of the crypt and over time label all epithe-
lial cells in the small intestine (Figure 2A, top) and colon
(Figure 2A, bottom). For each time point, we analyzed 200
well-oriented crypts in the proximal small intestine to
determine the percentage of crypts containing LacZ+ cells.
After 0.5, 1, 3, 7, 30, 60, 180, and 365 days, 26.1%, 30.6%,
36.1%, 27.7%, 22.6%, 14.4%, 8%, and 7% of the crypts,
respectively, are LacZ+ (Figure 2C). This reduction over
time likely reflects the presence of crypts labeled largely
in the Id1+ TA population. More than 80% of the crypts
labeled at 180 and 365 days are completely labeled as a
result of the marking of long-term self-renewing Id1+ pop-
ulations (Figure 2D). Animals treated with corn oil vehicle
control show no LacZ staining at any time point (data not
shown).
To demonstrate the multipotency of the ID1+ stem cells,
we performed double staining with differentiated cell
markers for goblet cells, Paneth cells, enteroendocrine cells,eports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 The Authors 717
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Figure 1. ID1 Is Detected in Stem and TA Cells in the Small Intestine and Colon
(A and B) Expression of ID1 protein in wild-type murine small intestine was detected using a rabbit monoclonal ID1 antibody. In (B), high-
magnification IHC (left) and immunofluorescence (right) show ID1 immunoreactivity in the TA cells, +4 position cells, and CBC cells.
(C and D) Low (C) and high (D) magnification IHC of ID1 in crypts of the colon.
(E and F) Expression of ID1 protein in normal human small intestine was detected by IHC using the rabbit monoclonal ID1 antibody. In (F),
high-magnification IHC shows ID1 immunoreactivity in TA cells, +4 position cells, and CBC cells as indicated.
(G and H) Low (G) and high (H) magnification IHC of ID1 in crypts of the human colon. In (B), (D), (F), and (H), [ marks TA cells,
marks +4 position cells, and * marks CBC cells.
(I) Colocalizationof LGR5and ID1 inmouse small intestine (left) and colon (right) by EGFPand ID1 staining in Lgr5-EGFPmice. *, CBC cells double
positive for EGFP and ID1; , CBC cells positive for EGFP but negative for ID1; , +4 position cells only positive for ID1. Scale bars, 50 mm.
See also Figures S1 and S2.
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ment. Paneth cells, periodic acid-Schiff (PAS)-positive
goblet cells (Figure 2E), chromogranin A-positive enteroen-
docrine cells (Figure 2F), and alkaline phosphatase-positive
enterocytes (Figure 2G) are all present in the LacZ-stained
clones on day 30 after tamoxifen induction. In contrast,718 Stem Cell Reports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 TheID1+ stem/progenitor cells at an early time point (1 day af-
ter induction) do not express any of the differentiation cell
markers (Figures 2H–2J). Taken together, these results indi-
cate that ID1marks the stem cells of the small intestine and
colon, which are capable of long-term self-renewal and
generate all cell types of the epithelium.Authors
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Figure 2. ID1 Labels Long-Term Repopulating Stem Cells in the Small Intestine and Colon
(A) LacZ staining of small intestine and colon from Id1-IRES-creERT2/Rosa26-lacZ mice from 1 day to 1 year after tamoxifen injection.
(B) Distribution of LacZ+ cells 12 hr after tamoxifen induction. Results are depicted as the means of three independent stretches of
proximal small intestine, with 50 positive crypts each. The distribution of LacZ+ cells within the stem cell compartment is indicated in
the pie chart on the right.
(C) Frequency of LacZ+ crypts/villi in the proximal small intestine at different time points after tamoxifen induction.
(D) Percentage of LacZ+ crypts that were completely labeled at different time points. For (C) and (D), 200 crypts in each proximal small
intestine from three mice were analyzed at all time points. Values are presented as the mean ± SD.
(E–G) Double labeling of LacZ-stained small intestine by PAS (E), chromogranin A (F), and alkaline phosphatase (G) in LacZ+ clones 30 days
after tamoxifen induction. *, goblet cells; , Paneth cell;:, enteroendocrine cell; [, enterocyte.
(H–J) Same as (E)–(G), but 1 day after tamoxifen induction. Note that double labeling was not observed. Scale bars, 50 mm.
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ID1, Stem Cells, and Colonic InjurySingle Adult Id1+ Stem Cells Form Crypt-Villus
Structures in Vitro
To determine whether Id1+ cells are able to generate stable
self-renewing intestinal epithelium organoids in vitro, we
isolated Id1-expressing populations by flow cytometryStem Cell Rusing an Id1VenusYFP knockin allele (Id1v/v) (Nam and Ben-
ezra, 2009) and cultured them as described previously
(Sato et al., 2009; Figure 3A). Small cyst-like structures
were visible after 2–3 days. After 6 days of culture, contin-
uous budding events started and dead cells appeared insideeports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 The Authors 719
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Figure 3. Single Id1+ Cells Generate Crypt-Villus Structure
(A) Flow-cytometric analysis of Id1venus+ epithelial cells from an Id1v/v small intestine. Gate was based on negative control from C57BL/J
intestine epithelial cells.
(B) Example of time-dependent organoid formation from a single Id1venus+ cell over a period of 10 days. Arrows mark defects in culture
plastic that were used as ‘‘landmarks’’ to track individual cells through early developmental phases to a mature organoid. Scale bar, 50 mm.
(C–F) Paraffin sections from single Id1venus+ cell-derived organoids stained with PAS (C, *, goblet and Paneth cells), Alcian blue (D, ,
goblet cells), chromogranin A antibody (E,:, enteroendocrine cells), and NBT/BCIP for alkaline phosphatase (F, [, enterocytes). NS,
nonspecific staining. Scale bars, 50 mm.
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dissociated mechanically and replated to form multiple
new organoids. This procedure could be repeated every
10–14 days for at least ten passages, and the organoids
did not display apparent morphological differences. Single
Id1Venus+ cells gave rise to cyst-like organoids (day 4) at an
average efficiency of 8%–10%; however, fully formed orga-
noids with a well-organized central lumen (villus domain)
and crypt domain were rarely observed (0.1% efficiency).
No single sorted Id1Venus cells were able to form organoids
and they typically died 1 day after plating. The organoids
derived from single Id1Venus+ cells gave rise to the four post-
mitotic differentiated cell types of the small intestine
epithelium, as evidenced by positive staining with PAS
(Paneth and goblet cells), Alcian blue (goblet cells; Figures
3C and 3D), the expression of chromogranin A (enteroen-
docrine cells; Figure 3E), and positive staining of alkaline
phosphatase (enterocytes) (Figure 3F). These data indicate
that single Id1+ cells have the capacity to function asmulti-
potent intestinal stem cells in vitro.
Loss of Id1 Sensitizes Mice to Colitis
Wenext determined whether ID1 was required for mucosal
homeostasis. Previous analyses suggested that the effects of720 Stem Cell Reports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 Theloss of individual Id family members are only observed
when stem cells are challenged by tissue damage or progen-
itor cell killing (Jankovic et al., 2007; Nam and Benezra,
2009). Treatment of wild-type mice with dextran sodium
sulfate (DSS) induces colitis that mimics clinical and histo-
logical features of human ulcerative colitis (Wirtz et al.,
2007). Treatment of wild-type mice with DSS led to an
increase in ID1 expression in the colonic epithelium (Fig-
ure S3). Id1 knockout mice and wild-type controls were
treated with DSS for 7 days followed by 14 days of plain
drinking water. A higher percentage of Id1/ mice had
severe diarrhea and bleeding compared with wild-type
controls upon DSS exposure (Figures 4A and 4B). Id1/
mice also had shorter colons and worse histology scores
characterized by loss of crypt structure, ulceration, and
infiltration of inflammatory cells (Figures 4C–4E). All
Id1/ mice died, whereas nearly all of the wild-type con-
trol mice survived (Figure 4F).
To determine whether the worse colitis observed in
Id1/ mice reflected an epithelial defect, we generated
intestinal epithelium-specific Id1 knockout (Id1DIEC) mice
by crossing Id1fl/fl mice (Nam and Benezra, 2009) with
B6.SJL-Tg(Vil-cre)997Gum/J transgenic mice, which express
Cre recombinase under the direction of the mouse villinAuthors
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Figure 4. Id1 Deficiency Sensitizes Mice to Worse Experimental Colitis
(A–F) Complete Id1 knockout.
(A–D and F) Mice were given 3% DSS (w/v) for 7 days followed by 14 days of plain drinking water. Severity of diarrhea, n = 6/group (A);
bleeding, n = 6/group (B); colon length, n = 10/group (C); histology score, n = 10/group (D); and mortality over time, n = 13/group (F)
were recorded.
(E) Representative histology (H&E staining) demonstrating worse injury in Id1/ mice. The percentage of mice with severe diarrhea was
calculated for the surviving mice in each group at each time point. The mean ± SEM for fecal blood score was determined for the surviving
mice in each group at each time point. Colon length and histology score were measured in mice at the time of sacrifice on day 8 and
summarized in box-and-whisker plots.
(G–L) Id1 deletion in epithelial cells.
(G–J and L) Id1fl/fl and Id1DIECmice were given DSS for 7 days followed by 14 days of plain drinking water. Severity of diarrhea, n = 6/group
(G); bleeding, n = 6/group (H); colon length, n = 4–11/group (I); histology score, n = 4–11/group (J); and mortality over time, n = 10–11/
group (L) were recorded.
(K) Representative histology (H&E staining) demonstrates worse injury in Id1DIEC mice. The percentage of mice with severe diarrhea was
calculated for the surviving mice in each group at each time point. The mean ± SEM for fecal blood score was determined for the surviving
mice in each group at each time point. Colon length and histology score were measured in mice that survived until day 21 and described
using the box-and-whisker plots.
(M and N) Effect of Id1 depletion on organoid formation and survival.
(M) Intestinal crypts were dissociated from wild-type and Id1/ mice (n = 5/group) and plated in Matrigel, and 24 hr later the fraction
of viable organoids was assessed and summarized using the box-and-whisker plot. Thirty 403 microscopic fields were analyzed for
each group.
(N) Representative images of crypt organoid populations from wild-type and Id1/ mice.
(O–Q) Effect of Id1 depletion in stem cells.
(O) Depletion of Id1 in Lgr5EGFP-IRES-CreERT2;Id1fl/fl/+ (Id1DLgr5) colon after tamoxifen induction. Note that crypts with high Lgr5 expression
(green) are devoid of Id1 (red).
(P and Q) Id1fl/fl and Id1DLgr5 mice were given DSS for 7 days followed by 14 days of plain drinking water. Colon lengths were compared
(n = 9/group; P) on day 8 and summarized using the box-and-whisker plot, and mortality over time (n = 29/group; Q) was recorded.
Scale bars, 50 mm.
See also Figures S3 and S4.
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ID1, Stem Cells, and Colonic Injurypromoter. Villin is broadly expressed in every cell of the
intestinal epithelium (Madison et al., 2002). The deletion
of ID1 in the unperturbed gut epithelium was continuous
and complete (Figure S4). Id1DIEC mice are viable, fertile,
normal in size, and do not display any gross physical or
behavioral abnormalities. In the absence of injury, deleting
Id1 from epithelial cells has no effect on the morphology
of the small intestine or colon. Moreover, no difference
in the crypt/villus ratio or crypt fission in control versus
Id1DIEC mice was observed (data not shown), suggesting
compensation by other ID family members under normal
physiological conditions. We then evaluated both the
severity of colitis and mortality in Id1DIEC mice. Similar to
what was observed in Id1/ mice, Id1DIEC mice exhibited
more severe colitis, including worse diarrhea and bleeding,
shorter colons, and worse histology scores compared with
Id1fl/fl mice (Figures 4G–4K). Sixty percent of Id1DIEC mice
died, whereas all animals in the Id1fl/fl control group sur-
vived (Figure 4L). No difference in any of these parameters
was observed between Id1fl/fl and Vil-cre-Id1+/+ mice, indi-
cating that Cre recombinase expression per se is not
responsible for the observed phenotypes. The fact that
both the severity of colitis and mortality increase when
Id1 is knocked out completely versus only in epithelial cells
suggests that endothelial Id1 may also be involved in the
pathophysiology of colitis.
Next, crypts were isolated from the intestines of wild-
type and Id1/ mice, and crypt organoid formation and
survival were assessed in vitro. In this culture system,
66.6% ± 5.7% of the intestinal crypts isolated from wild-
type mice were able to survive, compared with 43.1% ±
11.2% from the Id1/ mice (p < 0.01; Figures 4M and
4N). The defect observed in the Id1/ crypts under harsh
culture conditions may be reflective of the suboptimal
response to injury in the crypts of Id1-deficient mice
following DSS treatment.
To evaluate whether ID1 is essential for stem cell func-
tion within the crypt, we specifically knocked out Id1
in Lgr5+ cells by tamoxifen induction in Lgr5CreER/+;
Id1fl/fl mice, which we generated by crossing B6.129P2-
Lgr5tm1(cre/ERT2)Cle/J and Id1fl/fl mice. Although EGFP was
expressed uniformly in the crypts of the proximal small
intestine, expression was variegated in the distal small in-
testine and colon, as previously described (The Jackson
Laboratory, stock number 008875 database). Approxi-
mately 40% of the crypts in the colon expressed EGFP,
and ID1 was concomitantly deleted in these crypts after
tamoxifen administration (Figure 4O). Failure to observe
significant differences in the subjective clinical measure-
ments (diarrhea and bleeding) is likely a consequence of
incomplete deletion of Id1 in the colonic stem cells. None-
theless, similar to what was observed in the Id1/ and
Id1DIEC models, DSS treatment led to shorter colons and722 Stem Cell Reports j Vol. 3 j 716–724 j November 11, 2014 j ª2014 Theincreased mortality when Id1 was deleted in the Lgr5
compartment (Id1DLgr5) (Figures 4P and 4Q).
To begin to explore themechanismbywhich Id1 loss sen-
sitizes the colon to injury, we focused on the expression of
genes implicated in mitotic progression. ID1 is important
for proliferation in stem and progenitor cells in other tissue
types (Nam and Benezra, 2009) and proliferation defects
have been observed in the colonic epithelium in the DSS
model of colitis (Tessner et al., 1998). Hence, we reasoned
that loss of Id1 might sensitize the mice to DSS-induced
colonic injury because of an exacerbation of this prolifera-
tive defect. We examined the effects of Id1 loss in colonic
epithelium compared with wild-type controls in the
absence and presence of DSS treatment for 3 days. Strik-
ingly, 10 of 12 genes implicated in mitotic progression
were suppressed significantly in the Id1 deletion strain in
the presence of DSS relative to the other three groups (Table
S1). By contrast, the loss of Id1 in the epithelium in the
absence of DSS led to a statistically significant reduction
in the expression of only 3 of 12 genes. These results are
consistent with the notion that Id1 loss has the most pro-
found effect on proliferation in the presence of injury.
This could be a consequence of a reduced number of stem
cells. Further workwill be needed to explore this possibility.Conclusions
Taken together, our results demonstrate that ID1 is not
only a marker of adult intestinal stem/progenitor cells but
is also important for their function. The current findings
suggest a potential role for ID1 agonists in themanagement
of colitis or possibly radiation enteritis. Future studies
should explore the mechanism of how ID1 controls intes-
tinal stem cell function and the role of these ID1+ stem/
progenitor cells in colitis-related tumor development.EXPERIMENTAL PROCEDURES
Mice
Inbred male mice (8–10 weeks old) were used. Generation and
genotyping of Id1-IRES-CreERT2, Id1v/v, Id1/, and Id1fl/fl mice
have been described previously (Nam and Benezra, 2009). Inbred
C57BL6/J mice were used as wild-type controls in experiments
utilizing Id1/ mice in a C57BL6/J background. Lgr5-EGFP-IRES-
CreERT2, Rosa26-LacZ, and B6.SJL-Tg (Vil-cre) 997Gum/J mice
were obtained from The Jackson Laboratory.Tamoxifen Induction
Mice (8–10 weeks old) were injected intraperitoneally with 200 ml
tamoxifen in corn oil at 10 mg/ml.
DSS Colitis Model
Mice were treated with 3% DSS (molecular weight 36,000–50,000;
MP Biomedicals) for 7 days unless otherwise noted and thenAuthors
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scores (diarrhea and bleeding) and histology were determined
according to standard procedures (Wirtz et al., 2007) in blinded
studies. The animal protocol was approved by the Institutional
Animal Care and Use Committee at Memorial Sloan-Kettering
Cancer Center.
Histochemistry, IHC, and Immunofluorescence
Small intestines and colons were fixed in 4% paraformaldehyde
overnight at 4C. Anti-ID1 (Biocheck), anti-GFP/YFP (Invitrogen),
anti-Ki67 (Vector Labs), and anti-chromogranin A (Abcam) anti-
bodies were used. LacZ staining was performed as previously
described (Barker et al., 2007). PAS (Sigma-Aldrich), Alcian blue
(Dako), and alkaline phosphatase (Thermo Scientific) staining
was performed according to the manufacturers’ protocols. The
intensity of ID1 staining was determined by a gastrointestinal
pathologist (R.K.Y.) who was blinded to the treatment group.
Human tissues were analyzed under a protocol that was approved
by the Weill Cornell Medical College Institutional Review Board.
Crypt Analysis
Crypt isolation, cell dissociation, and culture were performed as
described previously (Sato et al., 2009).
Flow Cytometry
Venus (YFP)+ and Venus– cells were sorted with an Aria flow
cytometer (Becton Dickinson Biosciences). Single viable epithelial
cells were gated by forward scatter, side scatter, and pulse-width
parameter, and by negative staining for DAPI.
Quantitative Real-Time PCR
RNA was isolated from whole colon using the RNeasy mini kit
and poly A RNA was prepared with an Oligotex mRNA mini kit
(QIAGEN). Poly A RNA was reversed transcribed using murine
leukemia virus reverse transcriptase and oligo (dT)16 primer. The
resulting cDNAwas used for amplification using the primers listed
in Table S2. Glyceraldehyde 3 phosphate dehydrogenase (Gapdh) was
used as a normalization control. Real-time PCR was performed
using 23 SYBR Green PCR Master Mix on a 7500 Real-Time PCR
System (Applied Biosystems). Gene transcript levels were calcu-
lated using the DDCt method.
Statistics
A generalized linear mixed-effects model was used to evaluate
differences in the probability of having severe diarrhea (diarrhea
score > 2) between experimental groups. A linear mixed-effects
model was used to compare average bleeding scores across experi-
mental groups, taking into account both between- and within-
mouse variations in the endpoints. The nonparametric Wilcoxon
rank-sum test was used to examine differences between two ex-
perimental groups in various endpoints, including colon length,
histology scores, and percentage of viable organoids. Fisher’s
exact test was used to compare the distributions of the ordinal
IHC staining intensity between control and experimental mice.
To compare differences in survival between mice in two experi-
mental groups, the log rank test was used.Stem Cell RSUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and two tables
and can be found with this article online at http://dx.doi.org/
10.1016/j.stemcr.2014.09.012.
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